🇺🇸 SECWetour Robotics LtdCodex · 实盘不做把握 5/10不做原因:证据不足
北京时间·🕒 发布 20:00:15·⟳ 抓取 20:03:30 +3m15s·⚡ 决策 08-26 20:30:02 +26m32s·62.2 天前
Wetour Robotics签署最高7500万美元ATM售股协议,现有股东面临显著稀释
ATM稀释本身是直接负面催化,但当前无法完成强制行情与内部工具校验;因此保留风控负面信号,不给可执行SHORT订单。
📄 原文Wetour Robotics Ltd↗ 原文
----- ea0303201-6k_wetour.htm ----- 6-K 1 ea0303201-6k_wetour.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURI…
不做 Wetour Robotics Limited(WETO.US)
ATM稀释催化偏空且足以触发风控,但缺少stock_quote真实可成交报价、内部去重和event_study校验,不能按契约输出可执行SHORT。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
一手SEC 6-K确认Wetour Robotics签署ATM售股协议,后续424B5显示额度最高7500万美元;相对公开页面显示约2324万美元市值和约107.78万股基数,潜在发行规模远大于现有市值与流通盘,稀释和持续卖压明确偏空。但本轮未能取得stock_quote真实可成交价格,也未能调用强制内部去重、经验、案例库和event_study工具,不能满足ENTER的执行契约。
消息传播链
- Wetour Robotics提交6-K,披露与Rodman & Renshaw签署ATM sales agreement。
- StockTitan同步转录424B5并摘要最高7500万美元ATM额度、107.78万股当前股本和稀释测算。
关键理由
- ATM额度最高7500万美元,相对公开页面显示约2324万美元市值,潜在融资规模约为市值3.2倍,稀释压力极大。
- 按28.31美元假设价,424B5摘要测算ATM可发行约264.92万股,而当前约107.78万股,完全执行后股本将显著扩张。
- 公司披露现金仅约10.4万美元、累计亏损约875万美元并存在going-concern疑虑,融资需求使ATM实际使用概率不低。
主要风险
- 美股盘前尚未进入正常交易,且缺少stock_quote实时买卖盘,无法判断开盘跳空和可成交价格。
- WETO近期波动极端,8月中旬多日涨跌幅巨大,做空存在高波动与挤压风险。
反向证据
- 做空前查反向 · 来源 web · 日期 2026-07-22 · 影响 weakens
公司近期有北美商业协议、Qualcomm合作网络和NVIDIA Jetson相关叙事,但这些不抵消本次ATM的每股稀释。
检索:Wetour Robotics recent positive commercial agreements August 2026 WETO 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-08-21 · 影响 weakens
WETO近期单日涨跌幅极端,做空虽有基本面负催化但执行风险高。
检索:WETO stock price recent volatility August 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例不足使本应可考虑SHORT的事件降级为AVOID,仅输出风控风险。
方向:未能完成event_study,不能用量化先例校准方向;从机制上ATM大额融资对微盘股现有股东通常偏负面。
涨幅量级:缺少可验证的同市场高相似先例量化结果,未用于设置tp/sl。
形态:未完成样本化检索与日线测算,不能断言见光死概率。
原文全文
展开原文 · 5,146 字
----- ea0303201-6k_wetour.htm -----
6-K
1
ea0303201-6k_wetour.htm
REPORT OF FOREIGN PRIVATE ISSUER
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42536
Wetour Robotics Limited
(Translation of registrant’s name into English)
Room 7003
3300 N Interstate 35 Ste 700
Austin, TX 78705
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Information
contained in this Current Report on Form 6-K
Entry into Sales Agreement
On August 26, 2026, Wetour Robotics Limited (the
“Company”) entered into a certain sales agreement (the “Sales Agreement”) with Rodman & Renshaw LLC
(the “Sales Agent”) to issue and sell Company’s ordinary shares, par value US$0.01 per share (the “Ordinary Shares”),
from time to time, through an at the market offering under which the Sales Agent will act as sales agent and/or principal.
Subject to the terms and conditions of the Sales
Agreement, the Sales Agent has agreed to use its commercially reasonable efforts, consistent with its normal sales and trading practices
to place the Ordinary Shares, subject to, and in accordance with the information specified in a written notice from the Company, unless
the sale of the Ordinary Shares described therein has been suspended, cancelled or otherwise terminated.
The Sales Agent’s obligation to sell Ordinary
Shares under the Sales Agreement is subject to satisfaction of certain conditions, and other customary closing conditions. The sales under
the Sales Agreement will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule
415 under the Securities Act of 1933, including, without limitation, sales made directly on the Nasdaq Capital Market, on any other existing
trading market for the Ordinary Shares or to or through a market maker.
The Sales Agreement provides that the
commission payable to the Sales Agent for sales of Ordinary Shares with respect to which the Sales Agent acts as sales agent shall
be up to 3.0% of the gross proceeds of such sales. In addition, we will reimburse the Sales Agent for its reasonable, documented
out-of-pocket expenses, including legal fees, in accordance with the terms of the Sales Agreement. The remaining sales proceeds,
after deducting any such amounts and any transaction fees imposed by any governmental, regulatory or self-regulatory organization,
will equal our net proceeds.
The Sales Agreement contains customary representations
and warranties of the parties and indemnification and contribution provisions under which the Company and the Sales Agent have agreed
to indemnify each other against certain liabilities, including liabilities under the Securities Act. The Sales Agent and the Company have
the right, by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement.
The offering has been registered under the Securities
Act pursuant to the Company’s shelf registration statement on Form F-3 (Registration No. 333-294373), as supplemented by the prospectus
supplement dated August 26, 2026.
A copy of the Sales Agreement is attached as Exhibit
1.1 hereto and is incorporated herein by reference. The foregoing description of the Sales Agreement does not purport to be complete and
is qualified in its entirety by reference to such exhibit.
A copy of the opinion and consent of Ogier relating
to the validity of the securities to be issued in accordance with the Sales Agreement is filed herewith as Exhibit 5.1.
This Report shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale of the Ordinary Shares in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
1
Incorporation
by Reference
This report
on Form 6-K (the “Report”) shall be deemed to be incorporated by reference into the registration statements on
Form
S-8
(File No. 333-291960) and Form F-3 (File Nos.
333-294373
and
333-295457
) of the Company,
including any prospectuses forming a part of such registration statements, and to be a part thereof from the date on which this Report
is filed with the U.S. Securities and Exchange Commission (the “SEC”), to the extent not superseded by documents or reports
subsequently filed or furnished.
EXHIBITS
Exhibit
No.
Description
1.1
Sales Agreement, dated August 26, 2026, by and between Wetour Robotics Limited and Rodman & Renshaw LLC
5.1
Opinion of Ogier
23.1
Consent
of Ogier (included in Exhibit 5.1)
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Wetour Robotics Limited
By:
/s/ Nan Zheng
Name:
Nan Zheng
Title:
Chief Executive Officer
Date: August 26, 2026
3
6-K
1
ea0303201-6k_wetour.htm
REPORT OF FOREIGN PRIVATE ISSUER
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-42536
Wetour Robotics Limited
(Translation of registrant’s name into English)
Room 7003
3300 N Interstate 35 Ste 700
Austin, TX 78705
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Information
contained in this Current Report on Form 6-K
Entry into Sales Agreement
On August 26, 2026, Wetour Robotics Limited (the
“Company”) entered into a certain sales agreement (the “Sales Agreement”) with Rodman & Renshaw LLC
(the “Sales Agent”) to issue and sell Company’s ordinary shares, par value US$0.01 per share (the “Ordinary Shares”),
from time to time, through an at the market offering under which the Sales Agent will act as sales agent and/or principal.
Subject to the terms and conditions of the Sales
Agreement, the Sales Agent has agreed to use its commercially reasonable efforts, consistent with its normal sales and trading practices
to place the Ordinary Shares, subject to, and in accordance with the information specified in a written notice from the Company, unless
the sale of the Ordinary Shares described therein has been suspended, cancelled or otherwise terminated.
The Sales Agent’s obligation to sell Ordinary
Shares under the Sales Agreement is subject to satisfaction of certain conditions, and other customary closing conditions. The sales under
the Sales Agreement will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule
415 under the Securities Act of 1933, including, without limitation, sales made directly on the Nasdaq Capital Market, on any other existing
trading market for the Ordinary Shares or to or through a market maker.
The Sales Agreement provides that the
commission payable to the Sales Agent for sales of Ordinary Shares with respect to which the Sales Agent acts as sales agent shall
be up to 3.0% of the gross proceeds of such sales. In addition, we will reimburse the Sales Agent for its reasonable, documented
out-of-pocket expenses, including legal fees, in accordance with the terms of the Sales Agreement. The remaining sales proceeds,
after deducting any such amounts and any transaction fees imposed by any governmental, regulatory or self-regulatory organization,
will equal our net proceeds.
The Sales Agreement contains customary representations
and warranties of the parties and indemnification and contribution provisions under which the Company and the Sales Agent have agreed
to indemnify each other against certain liabilities, including liabilities under the Securities Act. The Sales Agent and the Company have
the right, by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement.
The offering has been registered under the Securities
Act pursuant to the Company’s shelf registration statement on Form F-3 (Registration No. 333-294373), as supplemented by the prospectus
supplement dated August 26, 2026.
A copy of the Sales Agreement is attached as Exhibit
1.1 hereto and is incorporated herein by reference. The foregoing description of the Sales Agreement does not purport to be complete and
is qualified in its entirety by reference to such exhibit.
A copy of the opinion and consent of Ogier relating
to the validity of the securities to be issued in accordance with the Sales Agreement is filed herewith as Exhibit 5.1.
This Report shall not constitute an offer to sell
or the solicitation of an offer to buy nor shall there be any sale of the Ordinary Shares in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
1
Incorporation
by Reference
This report
on Form 6-K (the “Report”) shall be deemed to be incorporated by reference into the registration statements on
Form
S-8
(File No. 333-291960) and Form F-3 (File Nos.
333-294373
and
333-295457
) of the Company,
including any prospectuses forming a part of such registration statements, and to be a part thereof from the date on which this Report
is filed with the U.S. Securities and Exchange Commission (the “SEC”), to the extent not superseded by documents or reports
subsequently filed or furnished.
EXHIBITS
Exhibit
No.
Description
1.1
Sales Agreement, dated August 26, 2026, by and between Wetour Robotics Limited and Rodman & Renshaw LLC
5.1
Opinion of Ogier
23.1
Consent
of Ogier (included in Exhibit 5.1)
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Wetour Robotics Limited
By:
/s/ Nan Zheng
Name:
Nan Zheng
Title:
Chief Executive Officer
Date: August 26, 2026
3
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。